Table 1.
Strain and Species of Bacteria | The Investigated Component of Bacteria | Experiment Duration | Cell Lines | Animal Model | Studed Group of People | Tests Used | Research Results | References |
---|---|---|---|---|---|---|---|---|
B. animalis 01 | Intact cells, culture supernatant, intracellular cell-free extracts |
Inhibition of linoleic acid peroxidation. Scavenge DPPH; scavenging effect on hydroxyl radicals and superoxide anions. |
All investigated probiotic forms had AO activity. | [59] | ||||
81 Lactobacilli strains of 6 different species | Cell-free culture supernatant | Test system based on E. coli MG1655 strains carrying plasmids encoding luminescent biosensors pSoxS-lux and pKatG-lux. |
51 strains demonstrated AO activity. | [61] | ||||
B. longum CCFM752, L. plantarum CCFM1149, L. plantarum CCFM10 |
Cell-free culture supernatant |
A7R5 | Determination of the angiotensin-II-induced ROS levels, catalase NADPH oxidase, and intracellular superoxide dismutase (SOD) activity. Regulation of the expression of NADPH oxidase activator 1 (Noxa1) and angiotensinogen. |
Suppression of the angiotensin-II-induced increases in ROS levels (all three strains); Inhibition of NADPH oxidase activation (B. longum CCFM752, L. plantarum CCFM1149); Enhancement of the intracellular SOD activity (L. plantarum CCFM1149); Downregulation of the expression of NADPH oxidase activator 1 (Noxa1) and angiotensinogen (B. longum CCFM752). |
[65] | |||
L. acidophilus ATCC 43121, L. acidophilus ATCC 4356, L. acidophilus 606, L. brevis ATCC 8287, L. casei YIT 9029, L. casei ATCC 393, L. rhamnosus GG |
Heat-killed cell (HK); the soluble polysaccharides (SP) components of bacterial cells |
Cancer cell lines HT-29, HeLa, MCF-7, U-87, HepG-2, U2Os, PANC-1, hEF | Antiproliferative effects on the cancer cells. Induction of apoptosis. Scavenging activity of the DPPH free radicals. |
HK of L. acidophilus 606 and L. casei ATCC 393 exhibited the most profound inhibitory activity in the all of tested cell lines; SP of L. acidophilus 606 evidenced the effective anticancer activity. |
[66] | |||
L. brevis MG000874 | Intact cells, intracellular cell-free extract |
8 weeks | Albino mice exposed to D-galactose- induced OS |
AO enzymes were quantified in liver, kidney, and serum of animals. |
The treated animals displayed improvement in SOD, CAT, and GST in all tissues, as well as GSH in the liver and serum. |
[68] | ||
L. fermentum U-21 | Intact cells | C. elegans (1–2 days); mice (23 days) | C57/BL6 mice, C. elegans exposed to paraquat-induced OS | The impact on the life span of C. elegans; A murine model of Parkinson’s disease |
The lifespan of the C. elegans was extended by 25%. L. fermentum U-21 ensured normal coordination of movements and the safety of dopaminergic neurons in the brain. |
[72] | ||
L. plantarum A7 (KC 355240, LA7) | Probiotic soy milk, 200 mL/day |
8 weeks | 24 type 2 diabetic kidney disease patients |
Malondialdehyde, 8-iso-prostaglandin F2a, oxidized glutathione, total antioxidant capacity (TAC), reduced glutathione (GSH), glutathione peroxidase, and glutathione reductase were measured in the serum. |
Oxidized glutathione concentration was significantly reduced; the levels of GSH, glutathione peroxidase, and glutathione reductase were significantly increased; no significant reduction in the 8-iso-prostaglandin F2α, malondialdehyde and no induction of TAC were detected. |
[75] | ||
Various probiotics and synbiotics | 27 articles that included 1363 subjects (709 cases and 699 controls) | Total antioxidant capacity (TAC), glutathione (GSH), superoxide dismutase (SOD), nitric oxide (NO), andmalondialdehyde (MDA) were taken into account. |
TAC, GSH, SOD, and NO were higher in probiotics (or synbiotics) group compared to controls. MDA level was lower than controls. |
[76] | ||||
L. acidophilus, L. casei, B. bifidum |
Capsules with intact cells (Tak Gen Zist Pharmaceutical Company, Tehran, Iran) |
12 weeks | Diabetic hemodialysis patients, 28 cases and 27placebos. | Plasma glucose, serum insulin, assessment-estimated insulin resistance, assessment-estimated beta-cell function and HbA1c, insulin sensitivity, serum C-reactive protein, plasma malondialdehyde, total iron-binding capacity, and plasma total antioxidant capacity were determined. |
Patients who received probiotic supplements showed significantly decreased plasma glucose, serum insulin, assessment-estimated insulin resistance and beta-cell function and HbA1c, insulin sensitivity, serum C-reactive protein, plasma malondialdehyde, and total iron-binding capacity. Patients showed an increase in plasma total antioxidant capacity. |
[74] |